Furthermore, patients with PD-L1-positive tumor cells accompanied by low PD-1-positive TIL counts exhibited poorer prognosis compared to those with PD-L1-negative DLBCL and high PD-1-positive TIL counts (219). This evidence concerns the gene CD274 and diffuse large B-cell lymphoma.